Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 375 of 499 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/30/14
End: 04/15/23
Due: 04/15/24
Phase: N/A
Priority: Normal
Start: 12/31/09
End: 08/31/12
Due: 08/31/13
Phase: N/A
Priority: Normal
Start: 10/31/01
End: 06/30/06
Due: 06/30/07
Phase: N/A
Priority: Normal
Start: 04/30/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/30/96
End: 12/31/08
Due: 12/31/09
Phase: N/A
Priority: Normal
Start: 02/28/11
End: 09/30/14
Due: 09/30/15
Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/09
End: 05/31/13
Due: 05/31/14
Phase: N/A
Priority: Normal
Start: 08/20/14
End: 06/15/17
Due: 06/15/18
Phase: N/A
Priority: Normal
Start: 02/27/14
End: 08/31/25
Due: 08/31/26
Phase: N/A
Priority: Normal
Start: 11/21/22
End: 09/01/33
Due: 09/01/34
Phase: N/A
Priority: Normal
Start: 10/29/19
End: 07/01/26
Due: 07/01/27
Phase: N/A
Priority: Normal
Start: 06/07/23
End: 05/31/27
Due: 05/31/28
Phase: N/A
Priority: Normal
Start: 01/22/14
End: 08/31/24
Due: 08/31/25
Phase: N/A
Priority: Normal
Start: 04/30/00
End: 02/29/08
Due: 02/28/09
Phase: N/A
Priority: Normal
Start: 10/31/99
End: 06/30/03
Due: 06/30/04
Phase: N/A
Priority: Normal
Start: 10/31/04
End: 09/30/14
Due: 09/30/15
Phase: N/A
Priority: Normal
Start: 11/30/96
End: 01/31/08
Due: 01/31/09
Phase: N/A
Priority: Normal
Start: 12/31/02
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 06/30/11
End: 08/31/14
Due: 08/31/15
Phase: N/A
Priority: Normal
Start: 04/30/09
End: 02/29/12
Due: 02/28/13
Phase: N/A
Priority: Normal
Start: 12/31/15
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/28/99
End: 07/31/05
Due: 07/31/06
Phase: N/A
Priority: Normal
Start: 01/31/00
End: 08/31/04
Due: 08/31/05
Phase: N/A
Priority: Normal
Start: 12/15/98
End: -
Due: -